Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04925817 · ClinicalTrials.gov registry record · Early Phase 1
3D Ultrasound Microvessel Imaging for Breast Masses
A Early Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 50
- Enrollment target
NCT04925817: Completed Early Phase 1 study, sponsored by Mayo Clinic.
NCT04925817 is a Early Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04925817, a Early Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
This early phase I trial studies how well 3D ultrasound microvessel imaging works for the diagnosis of breast mass. The 3D ultrasound microvessel imaging technology demonstrates significantly increased vessel detection sensitivity over conventional doppler methods without the need of using contrast agents. This study may improve cancer diagnosis and reduce unnecessary biopsy on benign tumors.
Interventions
- OTHER Electronic Health Record Review
- PROCEDURE Ultrasound Microvessel Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2023-05-18 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04925817
The ClinicalTrials.gov registry entry for NCT04925817 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Electronic Health Record Review is the first listed.
NCT04925817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04925817 about?
NCT04925817 is a clinical study titled "3D Ultrasound Microvessel Imaging for Breast Masses". This early phase I trial studies how well 3D ultrasound microvessel imaging works for the diagnosis of breast mass. The 3D ultrasound microvessel imaging technology demonstrates significantly increased vessel detection sensitivity over conventional doppler methods without the need of using contrast ...
What is the current status of trial NCT04925817?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 50 participants. The study started on 2021-08-19. Estimated completion is 2023-05-18.
What interventions are being tested in trial NCT04925817?
The interventions under investigation include: Electronic Health Record Review (OTHER), Ultrasound Microvessel Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT04925817?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.